A transformative approach
Our global information exchange platform will create seamless collaboration with health authorities via symbiotic relationships and efficiency that enable fewer, faster, and more harmonized global regulatory submissions
A revolutionary platform
Our solution is designed to accelerate communication, enable collaboration, and amplify innovation within the rigor of the regulatory process.
News & Events
Read the latest news from Accumulus Synergy
Merck Joins Accumulus Synergy as a Sponsor to Transform the Global Drug Regulatory Submission Process
Accumulus Synergy, a non-profit organization working to develop an information and data exchange platform aimed at transforming how life science innovators and health authorities worldwide interact, today announced Merck, known as MSD outside the United States and Canada, has joined Accumulus Synergy as a sponsor company.
Accumulus Synergy Announces the Appointment of Khushboo Sharma as Chief Regulatory Innovation Officer
Accumulus Synergy, a non-profit organization
working to develop an information and data exchange platform aimed at transforming
how drug innovators and health authorities worldwide interact, today announced the
appointment of Khushboo Sharma as its Chief Regulatory Innovation Officer and a
member of the company’s Executive Leadership Team (ELT).
Astrazeneca Joins Accumulus Synergy as a Sponsor to Accelerate the Delivery of Medicines to Patients
Accumulus Synergy, a nonprofit organization working to develop an information and data exchange platform aimed at transforming how drug innovators and health authorities worldwide interact, today announced AstraZeneca (LSE/STO/Nasdaq: AZN) has joined Accumulus Synergy as a sponsor company.
Accumulus Synergy Announces the Appointment of New Leadership Team Members
BURLINGAME – Accumulus Synergy, a nonprofit corporation working to develop an information and data exchange platform aimed at transforming how drug innovators and health authorities worldwide interact, today announced the appointment of three executive members of the company’s leadership team.